Your browser doesn't support javascript.
loading
Phase II study of alisertib as a single agent for treating recurrent or progressive atypical teratoid/rhabdoid tumor.
Upadhyaya, Santhosh A; Campagne, Olivia; Billups, Catherine A; Orr, Brent A; Onar-Thomas, Arzu; Tatevossian, Ruth G; Mostafavi, Roya; Myers, Jason R; Vinitsky, Anna; Moreira, Daniel C; Lindsay, Holly B; Kilburn, Lindsay; Baxter, Patricia; Smith, Amy; Crawford, John R; Partap, Sonia; Bendel, Anne E; Aguilera, Dolly G; Nichols, Kim E; Rampersaud, Evadnie; Ellison, David W; Klimo, Paul; Patay, Zoltan; Robinson, Giles W; Broniscer, Alberto; Stewart, Clinton F; Wetmore, Cynthia; Gajjar, Amar.
Affiliation
  • Upadhyaya SA; Department of Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
  • Campagne O; Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
  • Billups CA; Department of Biostatistics, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
  • Orr BA; Department of Pathology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
  • Onar-Thomas A; Department of Biostatistics, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
  • Tatevossian RG; Department of Pathology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
  • Mostafavi R; Department of Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
  • Myers JR; Center for Applied Bioinformatics, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
  • Vinitsky A; Department of Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
  • Moreira DC; Department of Global Pediatric Medicine, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
  • Lindsay HB; Department of Pediatrics, Texas Children's Cancer Center, Baylor College of Medicine, Houston, Texas, USA.
  • Kilburn L; Division of Oncology, Children's National Medical Center, Washington, DC, USA.
  • Baxter P; Department of Pediatrics, Texas Children's Cancer Center, Baylor College of Medicine, Houston, Texas, USA.
  • Smith A; Department of Hematology and Oncology, Arnold Palmer Hospital for Children, Orlando, Florida, USA.
  • Crawford JR; Department of Neurosciences and Pediatrics, University of California, San Diego and Rady Children's Hospital, San Diego, California, USA.
  • Partap S; Department of Neurology, Stanford University, Palo Alto, California, USA.
  • Bendel AE; Department of Hematology Oncology, Children's Minnesota, Minneapolis, Minnesota, USA.
  • Aguilera DG; Aflac Cancer and Blood Disorders Center, Atlanta, Georgia, USA.
  • Nichols KE; Department of Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
  • Rampersaud E; Center for Applied Bioinformatics, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
  • Ellison DW; Department of Pathology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
  • Klimo P; Department of Surgery, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
  • Patay Z; Department of Diagnostic Imaging, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
  • Robinson GW; Department of Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
  • Broniscer A; Division of Hematology Oncology, Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania, USA.
  • Stewart CF; Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
  • Wetmore C; Clinical Development, Neolukin Therapeutics, Seattle, USA.
  • Gajjar A; Department of Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
Neuro Oncol ; 25(2): 386-397, 2023 02 14.
Article in En | MEDLINE | ID: mdl-35652336

Full text: 1 Database: MEDLINE Main subject: Central Nervous System Neoplasms / Rhabdoid Tumor / Antineoplastic Agents Limits: Child / Humans Language: En Journal: Neuro Oncol Journal subject: NEOPLASIAS / NEUROLOGIA Year: 2023 Type: Article Affiliation country: United States

Full text: 1 Database: MEDLINE Main subject: Central Nervous System Neoplasms / Rhabdoid Tumor / Antineoplastic Agents Limits: Child / Humans Language: En Journal: Neuro Oncol Journal subject: NEOPLASIAS / NEUROLOGIA Year: 2023 Type: Article Affiliation country: United States